Adjunctive lacosamide for partial‐onset seizures: Efficacy and safety results from a randomized controlled trial

2009388 citationsJournal Articlebronze Open Access

Authors

Péter Halász · National Institute of Oncology

Reetta Kälviäinen · Kuopio University Hospital

Maria Mazurkiewicz‐Bełdzińska · Gdańsk Medical University

Felix Rosenow · Philipps University of Marburg

Pamela Doty

David Hébert

Timothy M. Sullivan

on behalf of the SP755 Study Group

Abstract

Results of this trial demonstrated the efficacy and tolerability of adjunctive lacosamide 200 and 400 mg/day and support that lacosamide may be an advantageous option for the treatment of partial-onset seizures in patients with epilepsy.

Topics & Keywords

Epilepsy research and treatment Pharmacological Effects and Toxicity Studies Neuroscience and Neuropharmacology Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Epilepsia

Volume 50, Issue 3, pp. 443-453

DOI: 10.1111/j.1528-1167.2008.01951.x

Field-Weighted Citation Impact: 20.80